MB Farmacijos rinkodara Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| - |
| 0 |
| 2024 |
|---|
| 47,521 |
| 23,761 |
| 5,642 |
| 5,642 |
| 2,821 |
| 100.00 |
| 11.87 |
| 5,642 |
| 3,693 |
| 0 |
| 9,335 |
| 0.12 |
| 0.65 |
| - |
| - |
| 11.87 |
| 5,642 |
| 2025 |
|---|
| 72,521 |
| 66,533 |
| 4,519 |
| 4,139 |
| 3,797 |
| 100.00 |
| 5.71 |
| 9,781 |
| 2,821 |
| 0 |
| 12,602 |
| 0.13 |
| 0.29 |
| - |
| - |
| 6.23 |
| 4,519 |
| 2025 |
|---|
| 72,521 |
| 66,533 |
| 4,519 |
| 4,139 |
| 3,797 |
| 100.00 |
| 5.71 |
| 9,781 |
| 2,821 |
| 0 |
| 12,602 |
| 0.13 |
| 0.29 |
| - |
| - |
| 6.23 |
| 4,519 |
Turnover (€)
2025
Turnover (€)
72,521 €53 % *
Sales per employee (€)
66,533 €180 % *
Profit before tax (€)
4,519 €-20 % *
Net Profit (€)
4,139 €-27 % *
Profit per employee (€)
3,797 €35 % *
Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
5.71 %-51.90 % *
Equity (€)
9,781 €73 % *
Amounts Payable And Liabilities (€)
2,821 €-24 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
12,602 €35 % *
Working capital requirement
0.13 8.33 % *
Debt-to-equity ratio
0.29 -55.38 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
6.23 %-47.51 % *
EBIT (€)
4,519 €-20 % *
